Biotech

All Articles

Pfizer, Valneva show lyme disease chance reliable for second enhancer

.Pfizer and Valneva might have regarding 2 even more years to stand by prior to they help make the v...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Let's study a conversation with Ayla Ellison, Fierce Biotech Editor-in-Chief and Michelle Benz as t...

New records show how Bayer's asundexian fell short to prevent strokes

.Bayer suspended the period 3 trial for its element XIa inhibitor asundexian behind time in 2013 aft...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is still set on taking its several sclerosis (MS) med tolebrutinib to the FDA, managers have...

Galapagos' stock up as fund shows intent to form its development

.Galapagos is happening under extra tension coming from capitalists. Having constructed a 9.9% conce...

Cell- focused Sana scoops initial CSO-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings a...

Allist settles Jacobio $21M, landing role in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has purchased itself a starring job in China's KRAS market, paying ...

ReNeuron leaving AIM substitution after missing out on fundraising goal

.ReNeuron has actually participated in the lengthy list of biotechs to leave London's objective stoc...

MBX apply for IPO to take opposition to Ascendis into phase 3

.MBX Biosciences has added to the current outbreak of IPO filings. The biotech, which submitted its ...

FDA expands probing right into Lykos' MDMA tests: WSJ

.For Lykos Therapeutics and also the company's prospective MDMA-assisted therapy for post-traumatic ...